Section Navigation
Section Navigation
- Module 2 Overview
Basic HIV Primary Care - 0%Lesson 1
Initial EvaluationActivities- 0%Lesson 2
Oral ManifestationsActivities- 2A.Core Concepts
- 2B.Implementing Oral Health Care into HIV Primary Care Settings Curriculum
- 2C.Intraoral Examination
- 2D.How to Check Patients for Oral Cancer
- 0%Lesson 3
Cutaneous ManifestationsActivities- 0%Lesson 4
Immunizations in AdultsActivities- 0%Lesson 5
Primary Care ManagementActivities- 0%Lesson 6
Screening for Mental Health ConditionsActivities- 0%Lesson 7
Substance Use DisordersActivities- 0%Lesson 8
Retention in HIV CareActivitiesLesson 3. Cutaneous Manifestations
Learning Objective Performance Indicators
- List common causes of cutaneous findings in persons with HIV
- Recognize diagnostic features of common HIV-related cutaneous manifestations in people with HIV
- Summarize appropriate treatment for common dermatological manifestations in people with HIV
- Explain treatment approaches to cutaneous Kaposi’s sarcoma
- Discuss vaccine strategies to prevent cutaneous zoster and anogenital warts
About this Lesson
Learning Objective Performance Indicators
- List common causes of cutaneous findings in persons with HIV
- Recognize diagnostic features of common HIV-related cutaneous manifestations in people with HIV
- Summarize appropriate treatment for common dermatological manifestations in people with HIV
- Explain treatment approaches to cutaneous Kaposi’s sarcoma
- Discuss vaccine strategies to prevent cutaneous zoster and anogenital warts
Activities in this Lesson
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
Funded byHealth Resources and Services Administration (HRSA)Created at University of WashingtonAn AETC ProgramPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE approved byOregon Nurses AssociationCopyright © 2025 National HIV CurriculumThe Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,172,994. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-d52d2330-2025-09-05-201745 - 0%Lesson 2
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine Edurant